Series C Funded Startups in France
The largest disclosed Series C in this France list is Mistral AI’s $2.0B round on 2025-09-11, which dwarfs the next-largest disclosed amounts (AKUR8 at $12…
The largest disclosed Series C in this France list is Mistral AI’s $2.0B round on 2025-09-11, which dwarfs the next-largest disclosed amounts (AKUR8 at $120M on 2024-09-16 and DNA Script at $200M on 2022-01-04), setting an extreme outlier at the top of the disclosed range. At the same time, the page shows clustering in time: 6 of the 41 rounds fall between 2024-06-11 and 2024-10-13 (including Step Pharma’s $44M on 2025-10-13 only slightly above the mid-range of many 2024 rounds), and several repeat Paris-based deals (e.g., SafeHeal $12M on 2025-09-08; YesWeHack $28M on 2024-06-11; Pennylane $43M on 2024-02-08). Sector-wise, AI appears repeatedly across multiple cities (Mistral AI 2025-09-11; Nabla $70M on 2025-06-17; AKUR8 $120M on 2024-09-16; Indy $44M on 2023-11-20; Prophesee and Corwave are additional nearby healthcare/AI-adjacent points), while disclosed biotech/health rounds also recur through 2022–2025 (e.g., Amolyt Pharma $139M on 2023-01-06; ImCheck Therapeutics $100M on 2022-06-13; Diabeloop $75M on 2022-06-02). Rounds span 2021-01-20 (Vulog) through 2025-11-04 (Upway), and 2 companies list amounts as undisclosed (Cosmo Tech on 2023-01-23; Prophesee on 2022-09-23).
Most recent rounds
41 shownRelated listings
Frequently asked
Which disclosed Series C round is the clear outlier in this France list, and what does it imply about the disclosed range?
Mistral AI’s $2.0B on 2025-09-11 is the only disclosed round in the billion-dollar range here, sitting far above the next-largest disclosed amounts such as DNA Script’s $200M (2022-01-04) and AKUR8’s $120M (2024-09-16).
Is there a time window where many Series C rounds cluster among the most recent 41 entries?
Yes: 6 of the 41 rounds occur between 2024-06-11 (YesWeHack $28M) and 2024-10-13 (Step Pharma $44M), including multiple 2024 spring/summer deals like Weenat $9M (2024-04-08) and Planity $49M (2024-02-20).
Do certain cities (especially Paris) show up disproportionately across these rounds?
Paris-based rounds recur across multiple years, including SafeHeal ($12M, 2025-09-08), YesWeHack ($28M, 2024-06-11), Pennylane ($43M, 2024-02-08), Indy ($44M, 2023-11-20), and Lydia ($103M, 2021-12-08). Other hubs appear too (Lyon for Nabla $70M on 2025-06-17 and ENYO Pharma $7M on 2025-06-12; Grenoble for UroMems $47M on 2024-06-25), but Paris shows sustained repeat entries.
Which sectors appear often enough to look like a pattern rather than single-off deals?
AI shows up repeatedly across the list (Mistral AI 2025-09-11 $2.0B; Nabla 2025-06-17 $70M; AKUR8 2024-09-16 $120M; Indy 2023-11-20 $44M; Prophesee 2022-09-23 undisclosed). Healthcare/biotech also recur across years, including Step Pharma ($44M, 2025-10-13), Amolyt Pharma ($139M, 2023-01-06), ImCheck Therapeutics ($100M, 2022-06-13), and Diabeloop ($75M, 2022-06-02).
Are there smaller disclosed rounds that sit at the low end, and how many entries are not disclosed?
The smallest disclosed amount is Weenat at $9M on 2024-04-08, while two additional entries have undisclosed amounts: Cosmo Tech (2023-01-23) and Prophesee (2022-09-23).
How does the distribution handle amounts when comparing the very recent rounds versus older ones?
Very recent deals include both mid-sized rounds and the largest outlier (Upway $60M on 2025-11-04 and Mistral AI $2.0B on 2025-09-11), whereas older years include large outliers like DNA Script at $200M (2022-01-04) alongside smaller disclosed rounds such as Vulog at $32M (2021-01-20).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.